EXCLUSIVE: Kobe Bryant In Talks to Settle ‘Black Mamba’ Battle
Kobe Bryant In Talks to Settle ‘Black Mamba’ Battle
theJasmineBRAND exclusively reports, Kobe Bryant is in talks to settle his battle over “Black Mamba” with a pharmaceutical company over the use of the name.
The NBA legend – via his company Kobe Inc – filed docs to block a company named Hi-Tech Pharmaceuticals from being able to register to trademark “Black Mamba HYPERRUSH”.
The pharma company wanted to trademark the name to sell diet pills. Kobe admitted he had filed docs after the pharma company, but he was the legit Black Mamba. He demanded they not be allowed to trademark the name and profit off his years of making the name valuable.
Hi-Tech demanded Kobe not be allowed to block them and said nobody would be confused. The battle has been going on for close to a year.
Recently, docs were filed revealing Kobe and the pharma company are currently negotiating for a possible settlement of this case. Both parties are asking for the deadlines to be suspended while they work out a deal to settle the entire case.
Follow us: @theJasmineBRAND on Twitter | theJasmineBRAND on Facebook| theJasmineBRAND_ on Instagram




Previous Article
Next Article
Pastor Convicted Of Using More Than $340K In Church Funds On Gambling, Luxury Dining & Personal Expenses
Nolan Wells’ Cause & Manner Of De@th Undetermined Following Family’s Autopsy, Attorney Ben Crump Says
Congratulations! “RHOP” Star Keiarna Stewart Announces Engagement To Greg Diggs
Kai Cenat’s Streamer University Sued For $330K After Attendee Claims He Was Used As Unpaid ‘Background Talent’ At Packed Auditions
Nationwide Cyclospora Outbreak Leaves Health Officials Scrambling To Identify Contaminated Food Source
Kandi Burruss’ Daughter Riley Addresses Backlash Over Accusing “Next Gen NYC” Costar Georgia McCann Of Ketamine Use & Threatening To Slap Her With Pizza
“Today” Show Co-Anchor Craig Melvin Targeted By Alleged Intruder Who Shouted N-Word & Lunged At Him Before Arrest
Media Personalities Peter Rosenberg & Ebro Darden Trade Shots In Heated Investment Debate